Zura Bio Statistics

Total Valuation

Zura Bio has a market cap or net worth of $84.10 million. The enterprise value is -$92.40 million.

Market Cap	84.10M
Enterprise Value	-92.40M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Zura Bio has 68.37 million shares outstanding. The number of shares has increased by 127.05% in one year.

Current Share Class	68.37M
Shares Outstanding	68.37M
Shares Change (YoY)	+127.05%
Shares Change (QoQ)	+4.14%
Owned by Insiders (%)	6.21%
Owned by Institutions (%)	56.16%
Float	46.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.55
P/TBV Ratio	0.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.16

Current Ratio	9.16
Quick Ratio	9.04
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.75% and return on invested capital (ROIC) is -28.80%.

Return on Equity (ROE)	-43.75%
Return on Assets (ROA)	-24.60%
Return on Invested Capital (ROIC)	-28.80%
Return on Capital Employed (ROCE)	-34.49%
Revenue Per Employee	n/a
Profits Per Employee	-$1.51M
Employee Count	30
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.38% in the last 52 weeks. The beta is 0.08, so Zura Bio's price volatility has been lower than the market average.

Beta (5Y)	0.08
52-Week Price Change	-59.38%
50-Day Moving Average	1.30
200-Day Moving Average	2.87
Relative Strength Index (RSI)	49.63
Average Volume (20 Days)	401,031

Short Selling Information

The latest short interest is 5.37 million, so 7.86% of the outstanding shares have been sold short.

Short Interest	5.37M
Short Previous Month	5.31M
Short % of Shares Out	7.86%
Short % of Float	11.53%
Short Ratio (days to cover)	19.78

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-55.19M
Pretax Income	-58.52M
Net Income	-45.39M
EBITDA	-55.18M
EBIT	-55.19M
Earnings Per Share (EPS)	-$0.60

Full Income Statement

Balance Sheet

The company has $176.50 million in cash and n/a in debt, giving a net cash position of $176.50 million or $2.58 per share.

Cash & Cash Equivalents	176.50M
Total Debt	n/a
Net Cash	176.50M
Net Cash Per Share	$2.58
Equity (Book Value)	160.02M
Book Value Per Share	2.25
Working Capital	159.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$28.08 million and capital expenditures -$75,000, giving a free cash flow of -$28.15 million.

Operating Cash Flow	-28.08M
Capital Expenditures	-75,000
Free Cash Flow	-28.15M
FCF Per Share	-$0.41

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Zura Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-127.05%
Shareholder Yield	n/a
Earnings Yield	-53.97%
FCF Yield	-33.47%

Analyst Forecast

The average price target for Zura Bio is $14.67, which is 1,087.85% higher than the current price. The consensus rating is "Buy".

Price Target	$14.67
Price Target Difference	1,087.85%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2